GH secretion reserve in subclinical hypercortisolism

Pituitary

Volumn 17, Issue 5, 2014, Pages 470-476

  Palmieri, Serena ^a   Morelli, Valentina ^a   Salcuni, Antonio Stefano ^b   Eller Vainicher, Cristina ^a   Cairoli, Elisa ^a   Zhukouskaya, Volha V ^a   Beck Peccoz, Paolo ^a   Scillitani, Alfredo ^b   Chiodini, Iacopo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Adrenal incidentaloma; Adrenalectomy; Growth hormone; Subclinical hypercortisolism

Indexed keywords

CORTICOTROPIN; HUMAN GROWTH HORMONE;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; AGED; BLOOD; BODY MASS; CUSHING SYNDROME; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; AGED; BODY MASS INDEX; CUSHING SYNDROME; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED;

EID: 84942749050     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0528-7     Document Type: Article

References (25)

1. Burguera B, Muruais C, Peñalva A, Dieguez C, Casanueva FF (1990) Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. Neuroendocrinology 51:51–58
2. Smals AE, Pieters GF, Smals AG, Benraad TJ, Kloppenborg PW (1986) Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing’s disease and in Cushing’s syndrome due to adrenocortical adenoma. Clin Endocrinol (Oxf) 24:401–407
3. Leal-Cerro A, Pumar A, Garcia–Garcia E, Dieguez C, Casanueva FF (1994) Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing’s syndrome. Clin Endocrinol (Oxf) 41:649–654
4. Mazziotti G, Giustina A (2013) Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol. doi:10.1038/nrendo.2013.5
5. Wehrenberg WB, Bergman PJ, Stagg L, Ndon J, Giustina A (1990) Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology 127:2705–2708
6. Leal-Cerro A, Soto A, Martínez MA, Alvarez P, Isidro L, Casanueva FF, Dieguez C, Cordido F (2002) Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing’s syndrome. Clin Endocrinol (Oxf) 57:745–749
7. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–797
8. Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S, Thalassinos NC (2004) Assessment of GH reserve before and after successful treatment of adult patients with Cushing’s syndrome. Clin Endocrinol (Oxf) 60:309–314
9. Mukherjee A, Murray RD, Teasdale GM, Shalet SM (2004) Acquired prolactin deficiency (APD) after treatment for Cushing’s disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Clin Endocrinol (Oxf) 60:476–483
10. Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing’s syndrome. Lancet 357:783–791
11. Chiodini I (2011) Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223–1236
12. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998–1003
13. Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. J Clin Endocrinol Metab 94:3207–3214
14. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V (2005) Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 15:837–844
15. Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A (1998) Subclinical Cushing’s syndrome in adrenal incidentaloma. Clinical Endocrinol (Oxf) 48:89–97
16. Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A (2000) Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. J Clin Endocrinol Metab 85:1310–1315
17. Tzanela M, Zianni D, Stylianidou Ch, Karavitaki N, Tsagarakis S, Thalassinos NC (2005) Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion. Clin Endocrinol (Oxf) 62:597–602
18. Murray RD, Adams JE, Shalet SM (2004) Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 89:1586–1591
19. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587–1609
20. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”) (2002) NIH Consens. State Sci Statements 19: 1–25
21. Ho KK (2007) 2007 GH deficiency consensus workshop participants consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European society for Pediatric Endocrinology, Lawson Wilkins society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695–700
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in men. Diabetologia 28:412–419
23. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, Ballotta E (2009) Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249:388–391
24. Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Pellegrini F, Copetti M, Beck-Peccoz P, Arosio M, Ambrosi B, Trischitta V, Scillitani A (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95:2736–2745
25. Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato R, Scillitani A, Beck-Peccoz P, Chiodini I (2012) Bone quality as measured by trabecular bone score (TBS) in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res 27:2223–2230